Aroa Biosurgery Limited
AROAF
$0.40
$0.000.00%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | 11.97M | 11.85M | 11.39M | 11.23M | 9.64M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 11.97M | 11.85M | 11.39M | 11.23M | 9.64M |
| Cost of Revenue | 1.58M | 1.57M | 1.54M | 1.52M | 1.53M |
| Gross Profit | 10.39M | 10.28M | 9.85M | 9.72M | 8.11M |
| SG&A Expenses | 10.44M | 10.33M | 10.34M | 10.20M | 8.58M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -181.00K | -179.10K | -212.50K | -209.60K | -293.40K |
| Total Operating Expenses | 13.48M | 13.34M | 12.91M | 12.74M | 11.36M |
| Operating Income | -1.51M | -1.49M | -1.52M | -1.50M | -1.72M |
| Income Before Tax | -888.10K | -878.80K | -1.31M | -1.29M | -1.86M |
| Income Tax Expenses | 118.90K | 117.70K | 18.40K | 18.10K | 42.70K |
| Earnings from Continuing Operations | -1.01M | -996.50K | -1.32M | -1.31M | -1.91M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -1.01M | -996.50K | -1.32M | -1.31M | -1.91M |
| EBIT | -1.51M | -1.49M | -1.52M | -1.50M | -1.72M |
| EBITDA | -990.60K | -980.30K | -1.00M | -987.70K | -1.22M |
| EPS Basic | 0.00 | 0.00 | 0.00 | 0.00 | -0.01 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | 0.00 | -0.01 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 344.55M | 344.55M | 344.38M | 344.38M | 343.28M |
| Average Diluted Shares Outstanding | 344.55M | 344.55M | 344.38M | 344.38M | 343.28M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
